| Schedule of reconciliation of the denominators used to calculate basic EPS and diluted EPS |
The reconciliations of the denominators used to calculate basic and diluted net income/(loss) per common share for the three and six months ended September 30, 2022 and 2021, respectively, are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, 2022 |
|
Three Months Ended September 30, 2021 |
|
Six Months Ended September 30, 2022 |
|
Six Months Ended September 30, 2021 |
| Basic net income/(loss) per common share |
|
|
|
|
|
|
|
| Net income/(loss) |
$ |
10,984 |
|
|
$ |
477 |
|
|
$ |
17,540 |
|
|
$ |
137 |
|
| Weighted-average common shares outstanding |
33,476,695 |
|
|
33,328,568 |
|
|
33,438,657 |
|
|
33,268,825 |
|
| Basic net income/(loss) per common share |
$ |
0.33 |
|
|
$ |
0.01 |
|
|
$ |
0.52 |
|
|
$ |
0.00 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, 2022 |
|
Three Months Ended September 30, 2021 |
|
Six Months Ended September 30, 2022 |
|
Six Months Ended September 30, 2021 |
| Diluted net income/(loss) per common share |
|
|
|
|
|
|
|
|
| Net income/(loss) |
|
$ |
10,984 |
|
|
$ |
477 |
|
|
$ |
17,540 |
|
|
$ |
137 |
|
| Weighted-average common shares outstanding |
|
33,476,695 |
|
|
33,328,568 |
|
|
33,438,657 |
|
|
33,268,825 |
|
| Common share equivalents: |
|
|
|
|
|
|
|
|
| Stock options |
|
1,536 |
|
|
— |
|
|
— |
|
|
1,667 |
|
| Restricted and performance stock units |
|
295,244 |
|
|
264,256 |
|
|
172,634 |
|
|
186,085 |
|
Weighted average shares outstanding – dilutive (1)
|
|
33,773,475 |
|
|
33,592,824 |
|
|
33,611,291 |
|
|
33,456,577 |
|
| Diluted net income/(loss) per common share |
|
$ |
0.33 |
|
|
$ |
0.01 |
|
|
$ |
0.52 |
|
|
$ |
0.00 |
|
(1) For the three months ended September 30, 2022 and 2021, 36,310 and 132,605 equity awards, respectively and for the six months ended September 30, 2022 and 2021, 113,559 and 144,664 equity awards, respectively, were not included in the calculation of diluted net income/(loss) per common share, as they would have had an anti-dilutive effect.
|